Vibhavadi Medical Center Valuation

Is VIBHA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VIBHA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VIBHA (THB2.08) is trading above our estimate of fair value (THB1.49)

Significantly Below Fair Value: VIBHA is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VIBHA?

Key metric: As VIBHA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for VIBHA. This is calculated by dividing VIBHA's market cap by their current earnings.
What is VIBHA's PE Ratio?
PE Ratio	27.4x
Earnings	฿1.02b
Market Cap	฿28.05b

VIBHA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.5x
Enterprise Value/EBITDA	19.4x
PEG Ratio	2.3x

Price to Earnings Ratio vs Peers

How does VIBHA's PE Ratio compare to its peers?

The above table shows the PE ratio for VIBHA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	24.5x
RAM Ramkhamhaeng Hospital	21.4x	15.3%	฿27.6b
SKR Sikarin	22.9x	n/a	฿19.3b
CHG Chularat Hospital	24.9x	10.3%	฿28.6b
PR9 Praram 9 Hospital	28.9x	11.4%	฿20.1b
VIBHA Vibhavadi Medical Center	27.4x	11.8%	฿28.0b

Price-To-Earnings vs Peers: VIBHA is expensive based on its Price-To-Earnings Ratio (27.4x) compared to the peer average (24.5x).

Price to Earnings Ratio vs Industry

How does VIBHA's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: VIBHA is expensive based on its Price-To-Earnings Ratio (27.4x) compared to the TH Healthcare industry average (22x).

Price to Earnings Ratio vs Fair Ratio

What is VIBHA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VIBHA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	27.4x
Fair PE Ratio	24.9x

Price-To-Earnings vs Fair Ratio: VIBHA is expensive based on its Price-To-Earnings Ratio (27.4x) compared to the estimated Fair Price-To-Earnings Ratio (24.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Master Style

฿12.7b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿42.25

-8.2%

-7.1%

E for L Aim

฿1.1b

Engages in the distribution of medical devices and equipment in Thailand.

EFORL-R

฿0.28

3.7%

12.0%

Safe Fertility Group

฿3.6b

Provides fertility medical center services in Thailand.

SAFE

฿12.00

-0.8%

-33.0%